Liposomal Glutathione Supplementation Restores TH1 Cytokine Response to Mycobacterium tuberculosis Infection in HIV-Infected Individuals

Journal of Interferon and Cytokine Research

Volumn 35, Issue 11, 2015, Pages 875-887

  Ly, Judy ^a   Lagman, Minette ^a   Saing, Tommy ^a   Singh, Manpreet Kaur ^a   Tudela, Enrique Vera ^a   Morris, Devin ^a   Anderson, Jessica ^a   Daliva, John ^a   Ochoa, Cesar ^b   Patel, Nishita ^b   Pearce, Daniel ^c   Venketaraman, Vishwanath ^a  

^a WESTERN UNIVERSITY OF HEALTH SCIENCES   (United States)

^b Western Diabetes Institute   (United States)

^c LOMA LINDA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; GLUTATHIONE; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 6; LIPOSOME; PLACEBO; REACTIVE OXYGEN METABOLITE; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; ANTIOXIDANT; CYTOKINE; DRUG CARRIER; IL12A PROTEIN, HUMAN; IL1B PROTEIN, HUMAN; INTERLEUKIN 12P35; TNF PROTEIN, HUMAN; TUMOR NECROSIS FACTOR;

ABSENCE OF SIDE EFFECTS; ADULT; AGED; ARTICLE; CD4+ T LYMPHOCYTE; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; CYTOKINE RESPONSE; GENETIC SUSCEPTIBILITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; IN VITRO STUDY; LIPOSOMAL DELIVERY; MYCOBACTERIUM TUBERCULOSIS; OXIDATIVE STRESS; PERIPHERAL BLOOD MONONUCLEAR CELL; PHARMACEUTICAL CARE; PRIORITY JOURNAL; TH1 CELL; TH2 CELL; TUBERCULOSIS; BIOSYNTHESIS; CD4 LYMPHOCYTE COUNT; COMPLICATION; IMMUNOLOGY; LUNG TUBERCULOSIS; METABOLISM; MIDDLE AGED; OXIDATION REDUCTION REACTION; YOUNG ADULT;

ADULT; AGED; ANTIOXIDANTS; CD4 LYMPHOCYTE COUNT; CYTOKINES; DRUG CARRIERS; GLUTATHIONE; HIV INFECTIONS; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-12 SUBUNIT P35; INTERLEUKIN-1BETA; LIPOSOMES; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; OXIDATION-REDUCTION; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; TH1 CELLS; TH2 CELLS; TUBERCULOSIS, PULMONARY; TUMOR NECROSIS FACTOR-ALPHA; YOUNG ADULT;

EID: 84946729847     PISSN: 10799907     EISSN: 15577465     Source Type: Journal    
DOI: 10.1089/jir.2014.0210     Document Type: Article

References (23)

1. Chung SS, Ho EC, Lam KS, Chung SK. 2003. Contribution of polyol pathway to diabetes-induced oxidative stress. J Am Soc Nephrol 14:S233-S236
2. Garba ML, Pilcher CD, Bingham AL, Eron J, Frelinger JA. 2002. HIV antigens can induce TGF-beta(1)-producing immunoregulatory CD8(+) T cells. J Immunol 168:2247-2254
3. Guerra C, Johal K, Morris D, Moreno S, Alvarado O, et al. 2012. Control of Mycobacterium tuberculosis growth by activated natural killer cells. Clin Exp Immunol 168:142-152
4. Guerra C, Morris D, Sipin A, Kung S, Franklin M, et al. 2011. Glutathione and adaptive immune responses against Mycobacterium tuberculosis infection in healthy and HIV infected individuals. PLoS One 6 (12):e28378
5. Herzenberg LA, DeRosa SC, Dubs JG, Roederer M, Anderson MT, et al. 1997. Glutathione deficiency is associated with impaired survival in HIV disease. Proc Natl Acad Sci U S A 94:1967-1972
6. Kehrl JH, Wakefield LM, Roberts AB, Jakowlew S, Alvarez- Mon M, et al. 1986. Production of transforming growth factor beta by human T lymphocytes and its potential role in the regulation of T cell growth. J Exp Med 163:1037-1050
7. Letterio JJ, Roberts AB. 1998. Regulation of immune responses by TGF-beta. Annu Rev Immunol 16:137-161
8. Lotz M, Seth P. 1993. TGF beta and HIV infection. Ann N Y Acad Sci 685:501-511
9. Lushchak VI. 2012. Glutathione homeostasis and functions: potential targets for medical interventions. J Amino Acids 2012:736837
10. Maeda K, Mehta H, Drevets DA, Coggeshall KM. 2010. IL-6 increases B-cell IgG production in a feed-forward proinflammatory mechanism to skew hematopoiesis and elevate myeloid production. Blood 115:4699-4706
11. Morris D, Gonzalez B, Khurasany M, Kassissa C, Luong J, et al. 2013a. Characterization of dendritic cell and regulatory T cell functions against Mycobacterium tuberculosis infection. Biomed Res Int 2013:402827
12. Morris D, Guerra C, Donohue C, Oh H, Khurasany M, et al. 2012. Unveiling the mechanisms for decreased glutathione in individuals with HIV infection. Clin Dev Immunol 2012: 734125
13. Morris D, Guerra C, Khurasany M, Guilford F, Saviola B, et al. 2013b. Glutathione supplementation improves macrophage functions in HIV. J Interferon Cytokine Res 33:270-279
14. Morris D, Khurasany M, Nguyen T, Kim J, Guilford F, et al. 2013c. Glutathione and infection. Biochim Biophys Acta 1830:3329-3349
15. Morris D, Ly J, Chi PT, Daliva J, Nguyen T, Soofer C, Chen YC, Lagman M, Venketaraman V. 2014. Glutathione synthesis is compromised in erythrocytes from individuals with HIV. Front Pharmacol 5:73
16. Morris D, Nguyen T, Kim J, Kassissa C, Khurasany M, et al. 2013d. An elucidation of neutrophil functions against Mycobacterium tuberculosis infection. Clin Dev Immunol 2013: 959650
17. Piot P, Bartos M, Ghys PD, Walker N, Schwartlander B. 2001. The global impact of HIV/AIDS. Nature 410:968-973
18. Ray K, Gupta SM, Bala M, Muralidhar S, Kumar J. 2006. CD4/ CD8 lymphocyte counts in healthy, HIV-positive individuals & AIDS patients. Indian J Med Res 124:319-330
19. Romagnani S. 2000. T-cell subsets (Th1 versus Th2). Ann Allergy Asthma Immunol 85:9-18; quiz 18, 21
20. Trinchieri G. 1997. Cytokines acting on or secreted by macrophages during intracellular infection (IL-10, IL-12, IFN-g). Curr Opin Immunol 9:17-23
21. Venketaraman V, Morris D, Donohou C, Sipin A, Kung S, et al. 2011. Role of Cytokines and Chemokines in HIV Infection, HIV and AIDS - Updates on Biology, Immunology, Epidemiology and Treatment Strategies, Dr. Nancy Dumais (Ed.). Vera Tudela E, Manpreet Kaur Singh, Minette Lagman, Judy Ly, Nishita Patel, Cesar Ochoa, Vishwanath Venketaraman. 2014. Cytokine levels in plasma samples of individuals with HIV infection. Austin J Clin Immunol 1(1):1003
22. Wassmann S, Stumpf M, Strehlow K, Schmid A, Schieffer B, et al. 2004. Interleukin-6 induces oxidative stress and endothelial dysfunction by overexpression of the angiotensin II type 1 receptor. Circ Res 94:534-541
23. WHO. 2014. Global update on the health sector response to HIV, 2014. (2014, July 1)